Blog

Day: November 16, 2026

NEWS

Why CMC Matters in Biologics Development

Biopharmaceutical innovators developing recombinant proteins, nanobodies, plasmid DNA, vaccines, mRNA, and circRNA face a recurring set of obstacles: low yields and stability issues in mammalian